Reviewing biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV)

biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability.

Profitability

This table compares biote and Elevance Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
biote	-1.08%	-8.61%	4.61%
Elevance Health	2.55%	14.97%	5.31%

Analyst Ratings

This is a breakdown of current ratings and price targets for biote and Elevance Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	1	1	1	1	2.50
Elevance Health	0	7	15	0	2.68

biote presently has a consensus target price of $2.50, indicating a potential upside of 124.01%. Elevance Health has a consensus target price of $456.48, indicating a potential upside of 6.24%. Given biote’s higher possible upside, research analysts plainly believe biote is more favorable than Elevance Health.

Risk and Volatility

biote has a beta of 1.73, suggesting that its share price is 73% more volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.

Institutional & Insider Ownership

21.7% of biote shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 32.4% of biote shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares biote and Elevance Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$183.53 million	0.22	$27.05 million	($0.10)	-11.16
Elevance Health	$199.12 billion	0.47	$5.66 billion	$23.45	18.32

Elevance Health has higher revenue and earnings than biote. biote is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Summary

Elevance Health beats biote on 11 of the 15 factors compared between the two stocks.

About biote

Biote Inc. (NASDAQ: BTMD) is a healthcare company focused on hormone optimization and personalized care. Through its provider-enabled platform, the company supports physicians and other healthcare professionals who offer bioidentical hormone replacement therapy and related wellness services. The company’s offerings include the Biote Method, a hormone pellet therapy program designed for eligible men and women, as well as nutritional supplements, patient education, clinical training, and practice-management support.

About Elevance Health

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.